Sheaff Brock Investment Advisors, LLC Bristol Myers Squibb CO Call Options Transaction History

Sheaff Brock Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $328,549 - $372,650	5,000 Added 500.0%	6,000 $415,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $273,920 - $324,360	-4,000 Reduced 80.0%	1,000 $71,000
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $650 - $384,200	5,000 New	5,000 $355,000
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $29,670 - $33,370	500 Added 12.5%	4,500 $284,000
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $230,960 - $261,720	-4,000 Reduced 50.0%	4,000 $248,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $393,680 - $513,520	8,000 New	8,000 $514,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.